As of May 22
| -0.04 / -2.12%|
The 4 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 5.88, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +217.57% increase from the last price of 1.85.
The current consensus among 4 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.